Skip to main content

Year: 2025

SCHMID Announces Successful Delivery and Installation of its InfinityLine C+ System to a Leading Japanese Advanced Packaging Customer

SCHMID Group secures Major Orders for AI Server PCB Production Equipment FreudenstadtIn one project, SCHMID will deliver a complete wet-process equipment setup featuring its advanced V+ and H+ systems. The second project involves the supply of technically critical horizontal H+ machines, marking a breakthrough outside the typical PCB and IC-substrate business.FREUDENSTADT, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) — The SCHMID Group, a leading global provider of equipment and solutions for the electronics industry, today announced the successful delivery and installation of its first InfinityLine C+ system for a leading Japanese customer in the Advanced Packaging and high-end substrate market. The InfinityLine C+ represents SCHMID’s next-generation vertical spin process technology, designed to deliver best-in-class uniformities,...

Continue reading

Nasdaq Halts MaxsMaking Inc.

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in MaxsMaking Inc. (Nasdaq: MAMK) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MAMK from 04:00:00 on November 17, 2025 to 23:59:00 on December 1, 2025. The last sale price of the company’s shares was $13.00.  More information about the SEC’s order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104180.pdf. Trading will remain halted until MaxsMaking Inc. has fully satisfied Nasdaq’s request for additional information. For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site. For more information...

Continue reading

Alchip Technologies Reports 2025 Third Quarter Financial Results

Profitability Holding SteadyRevenue Breakdown by RegionThe North America region accounted for nearly three quarts of Alchip Technologies’ third quarter 2025 revenue.Taipei, Taiwan, Dec. 02, 2025 (GLOBE NEWSWIRE) — Alchip Technologies reported that third quarter profits held steady on a quarter-by-quarter basis despite a decline quarterly revenue. Third quarter 2025 net income of $44.3 million is 3.1% over 2025 second quarter net income of $42.9 million. Pre-tax profit for the third quarter of 2025 registered $53.1 million is up 2.2% from 2025 second quarter pre-tax profit of $52 million.  Third quarter 2025 gross profit of $61.7 million is up slightly from 2025 second quarter gross profit of $61.6 million. Third quarter 2025 revenue declined to $223 million, from second quarter 2025 revenue of $297.4 million. Chairman,...

Continue reading

SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company

TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a controlling interest of approximately 75%, has entered into a non-binding term sheet (the “Term Sheet”) with an Israeli-based pioneering quantum computing bio data company focused on quantum-enabled clinical analytics (the “Target Company”). Pursuant to the Term Sheet, NeuroThera will acquire a 55% equity interest in the Target Company from certain selling shareholders of the Target Company (the “Selling Shareholders”), calculated on a post transaction fully diluted basis, in consideration for the...

Continue reading

Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc

PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that its stockholders approved, among other things, the proposed business combination with Hyperliquid Strategies Inc (“HSI”) and Rorschach I LLC at its special meeting of stockholders. The final voting results for the special meeting will be filed in a Form 8-K with the U.S. Securities and Exchange Commission. About Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics Holdings, Inc. is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. Known as FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human...

Continue reading

Raymond James Announces Full Redemption of its Series B Preferred Stock and Related Depositary Shares

St. Petersburg, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) — On December 2, 2025, Raymond James Financial, Inc. (NYSE: RJF) announced that, on January 2, 2026, it will redeem all 80,500 outstanding shares of its 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock, par value $0.10 per share (the “Series B Preferred Stock”). The redemption of the Series B Preferred Stock will trigger the redemption of the related depositary shares, each representing a 1/40th interest of a share of Series B Preferred Stock (the “Series B Depositary Shares”) (NYSE: RJF PrB) (CUSIP: No. 754730 406). The redemption prices will be equal to $1,000.00 per share of Series B Preferred Stock and $25.00 per Series B Depositary Share. The redemption prices noted herein do not include declared and unpaid dividends, if any, prior to the redemption...

Continue reading

Rapid7 and HITRUST Partner to Automate Cybersecurity Assurance, Reducing Cost and Complexity Across Regulated Industries

New collaboration integrates Rapid7 platform with HITRUST certification program to help organizations move from periodic audits to continuous compliance BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Today, Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, and HITRUST, the leading provider of cybersecurity and AI assurances used in third-party and internal risk, security and compliance management, announced a strategic partnership to help organizations automate compliance and lower the cost of assurance. This new integration brings together Rapid7’s Surface Command, which provides organizations with a complete view of their attack surface, with HITRUST’s assurance framework. Through this new partnership, Rapid7 customers can automatically collect, map, and validate controls against HITRUST standards, reducing...

Continue reading

Arteris Selected by Black Sesame Technologies for Next Generation of Intelligent Driving Silicon

Arteris’ Ncore 3 and FlexNoC 5 network-on-chip interconnect IPs enable data movement with data coherency, enhancing overall performance, efficiency, and time to market for advanced automotive SoCs. CAMPBELL, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today announced that Black Sesame Technologies has licensed Arteris’ Ncore 3 cache coherent network-on-chip (NoC) IP and FlexNoC 5 non-coherent NoC IP with physical awareness. Arteris technology will be used to optimize on-chip connectivity and data movement for SoCs and SoC-based solutions that deliver full-stack autonomous driving capabilities for the next generation of intelligent vehicles. Black Sesame Technologies addresses the needs of today’s automotive industry...

Continue reading

Quickbase Acquires Juiced Technologies

Acquisition will extend what’s possible in Quickbase and make it easier to get started with Juiced’s advanced add-ons BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Quickbase, the AI operations platform, today announced that it has acquired Juiced Technologies (“Juiced”), a long-standing partner specializing in developing and hosting Quickbase add-ons. The acquisition will extend Quickbase’s native functionality with Juiced’s advanced document formatting capabilities and e-signature, geomapping, and email-to-text features. For more than two decades, Juiced has developed a suite of advanced, customizable add-ons that not only complement the core Quickbase platform, but also extend what’s possible for Quickbase users—designed with an intuitive user experience in mind. Its portfolio, including JuicedSign, Exact Forms Plus, QB Maps, XL...

Continue reading

LPL Financial Welcomes Kūpono Wealth Planning

SAN DIEGO, Dec. 02, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that Brandon Wallis, CFP®, CRPS™, of Kūpono Wealth Planning has joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. He reported serving approximately $145 million in advisory, brokerage, and retirement plan assets* and joins LPL from Edward Jones. Kūpono Wealth Planning is based in Mililani, Hawaiʻi, just 20 miles from Honolulu, and proudly serves the Central Oahu and North Shore communities. With two decades of industry experience, Brandon has called Hawaiʻi home since 2007. Brandon works with a diverse clientele, including individuals who have retired within the last decade, those planning to retire in the next five years, as well as many mainland transplants, medical professionals, and small business owners. “We...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.